Ian F. Smith, EVP, COO at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 23,375 shares at $166.57 ($3.9M) on 2018-06-29, disclosed to the SEC on 2018-07-03.
Scheduled sale ($3.9M) by EVP, COO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $165.22 | 4,741 | $783K | 20.2% |
| 2 | $166.57 | 18,634 | $3.1M | 79.8% |
| Total | $166.30 avg | 23,375 | $3.9M | 100% |
| Filing → |
| VRTX | SELL | 2018-05-16 | $34K | — | Filing → |
| VRTX | SELL | 2018-05-15 | $635K | — | Filing → |
| ACOR | SELL | 2018-05-04 | $237K | — | Filing → |